Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $3.17 down -1.86% from its previous closing price of $3.23. In other words, the price has decreased by -$1.86 from its previous closing price. On the day, 2.12 million shares were traded. RCKT stock price reached its highest trading level at $3.26 during the session, while it also had its lowest trading level at $3.01.
Ratios:
For a deeper understanding of Rocket Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.30 and its Current Ratio is at 7.30. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On July 25, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $4.
Evercore ISI Downgraded its Outperform to In-line on May 30, 2025, while the target price for the stock was maintained at $5.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 14 ’25 when Militello John sold 28,918 shares for $3.96 per share. The transaction valued at 114,581 led to the insider holds 67,006 shares of the business.
Militello John bought 28,918 shares of RCKT for $114,581 on Oct 14 ’25. On Aug 27 ’25, another insider, Bjork Elisabeth, who serves as the Director of the company, bought 10,000 shares for $3.41 each. As a result, the insider paid 34,100 and bolstered with 40,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 343064448 and an Enterprise Value of 145351456.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.68, which has changed by -0.811981 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $17.83, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is -7.78%, while the 200-Day Moving Average is calculated to be -39.74%.
Shares Statistics:
For the past three months, RCKT has traded an average of 3.55M shares per day and 1765370 over the past ten days. A total of 108.21M shares are outstanding, with a floating share count of 98.95M. Insiders hold about 8.57% of the company’s shares, while institutions hold 87.28% stake in the company. Shares short for RCKT as of 1760486400 were 12397844 with a Short Ratio of 3.49, compared to 1757894400 on 14892250. Therefore, it implies a Short% of Shares Outstanding of 12397844 and a Short% of Float of 22.37.
Earnings Estimates
Its stock is currently analyzed by 13.0 different market analysts. The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.37 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.66 and -$2.19 for the fiscal current year, implying an average EPS of -$2.02. EPS for the following year is -$1.15, with 13.0 analysts recommending between $0.69 and -$1.96.
